Skip to main content
NCBI home page
Comparative and Functional Genomics logoLink to Comparative and Functional Genomics
. 2003 Dec;4(6):628–634. doi: 10.1002/cfg.333

Biobanks for Genomics and Genomics for Biobanks

Anne Cambon-Thomsen 1,✉, Pascal Ducournau 1,2, Pierre-Antoine Gourraud 1, David Pontille 1,3
PMCID: PMC2447308  PMID: 18629026

Abstract

Biobanks include biological samples and attached databases. Human biobanks occur in research, technological development and medical activities. Population genomics is highly dependent on the availability of large biobanks. Ethical issues must be considered: protecting the rights of those people whose samples or data are in biobanks (information, autonomy, confidentiality, protection of private life), assuring the non-commercial use of human body elements and the optimal use of samples and data. They balance other issues, such as protecting the rights of researchers and companies, allowing long-term use of biobanks while detailed information on future uses is not available. At the level of populations, the traditional form of informed consent is challenged. Other dimensions relate to the rights of a group as such, in addition to individual rights. Conditions of return of results and/or benefit to a population need to be defined. With ‘large-scale biobanking’ a marked trend in genomics, new societal dimensions appear, regarding communication, debate, regulation, societal control and valorization of such large biobanks. Exploring how genomics can help health sector biobanks to become more rationally constituted and exploited is an interesting perspective. For example, evaluating how genomic approaches can help in optimizing haematopoietic stem cell donor registries using new markers and high-throughput techniques to increase immunogenetic variability in such registries is a challenge currently being addressed. Ethical issues in such contexts are important, as not only individual decisions or projects are concerned, but also national policies in the international arena and organization of democratic debate about science, medicine and society.

Full Text

The Full Text of this article is available as a PDF (141.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderlik M. R., Rothstein M. A. Privacy and confidentiality of genetic information: what rules for the new science? Annu Rev Genomics Hum Genet. 2001;2:401–433. doi: 10.1146/annurev.genom.2.1.401. [DOI] [PubMed] [Google Scholar]
  2. Anderlik Mary. Commercial biobanks and genetic research: ethical and legal issues. Am J Pharmacogenomics. 2003;3(3):203–215. doi: 10.2165/00129785-200303030-00006. [DOI] [PubMed] [Google Scholar]
  3. Austin Melissa A., Harding Sarah, McElroy Courtney. Genebanks: a comparison of eight proposed international genetic databases. Community Genet. 2003;6(1):37–45. doi: 10.1159/000069544. [DOI] [PubMed] [Google Scholar]
  4. Barbour Virginia. UK Biobank: a project in search of a protocol? Lancet. 2003 May 17;361(9370):1734–1738. doi: 10.1016/S0140-6736(03)13377-6. [DOI] [PubMed] [Google Scholar]
  5. Blatt R. J. R. Banking biological collections: data warehousing, data mining, and data dilemmas in genomics and global health policy. Community Genet. 2000;3(4):204–211. doi: 10.1159/000051140. [DOI] [PubMed] [Google Scholar]
  6. Cambon-Thomsen A., Rial-Sebbag E. Aspects éthiques des banques d'échantillons biologiques. Rev Epidemiol Sante Publique. 2003 Feb;51(1 Pt 2):101–110. [PubMed] [Google Scholar]
  7. Cambon-Thomsen A., Rial-Sebbag E., Duchier J. Aspects éthiques et réglementaires des collections d'échantillons biologiques: synthèse, questions pratiques et propositions. Rev Epidemiol Sante Publique. 2003 Feb;51(1 Pt 2):121–126. [PubMed] [Google Scholar]
  8. Cambon-Thomsen Anne. Assessing the impact of biobanks. Nat Genet. 2003 May;34(1):25–26. doi: 10.1038/ng0503-25b. [DOI] [PubMed] [Google Scholar]
  9. Chadwick R., Berg K. Solidarity and equity: new ethical frameworks for genetic databases. Nat Rev Genet. 2001 Apr;2(4):318–321. doi: 10.1038/35066094. [DOI] [PubMed] [Google Scholar]
  10. Confer D. L. The National Marrow Donor Program. Meeting the needs of the medically underserved. Cancer. 2001 Jan 1;91(1 Suppl):274–278. doi: 10.1002/1097-0142(20010101)91:1+<274::aid-cncr18>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  11. Confer D. L. Unrelated marrow donor registries. Curr Opin Hematol. 1997 Nov;4(6):408–412. doi: 10.1097/00062752-199704060-00008. [DOI] [PubMed] [Google Scholar]
  12. Dahlquist Gisela. Biobankerna måste utnyttjas rationellt. Sluta gräla om äganderätten! Lakartidningen. 2002 Sep 5;99(36):3484–3485. [PubMed] [Google Scholar]
  13. Deschênes M., Cardinal G., Knoppers B. M., Glass K. C. Human genetic research, DNA banking and consent: a question of 'form'? Clin Genet. 2001 Apr;59(4):221–239. doi: 10.1034/j.1399-0004.2001.590403.x. [DOI] [PubMed] [Google Scholar]
  14. Dodson K. L., Coppo P. A., Confer D. L. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation. Clin Transpl. 1999:121–127. [PubMed] [Google Scholar]
  15. Foissac A., Fort M., Clayton J., Abbal M., Raffoux C., Moine A., Bensa J. C., Bignon J. D., Mercier P., Cambon-Thomsen A. Microsatellites in the HLA region: HLA prediction and strategies for bone marrow donor registries. Transplant Proc. 2001 Feb-Mar;33(1-2):491–492. doi: 10.1016/s0041-1345(00)02107-2. [DOI] [PubMed] [Google Scholar]
  16. Gahrton G., van Rood J. J., Oudshoorn M., World Marrow Donor Association (WMDA) The World Marrow Donor Association (WMDA): its goals and activities. Bone Marrow Transplant. 2003 Jul;32(2):121–124. doi: 10.1038/sj.bmt.1704097. [DOI] [PubMed] [Google Scholar]
  17. Hirtzlin Isabelle, Dubreuil Christine, Préaubert Nathalie, Duchier Jenny, Jansen Brigitte, Simon Jürgen, Lobato De Faria Paula, Perez-Lezaun Anna, Visser Bert, Williams Garrath D. An empirical survey on biobanking of human genetic material and data in six EU countries. Eur J Hum Genet. 2003 Jun;11(6):475–488. doi: 10.1038/sj.ejhg.5201007. [DOI] [PubMed] [Google Scholar]
  18. Hodgson Shirley V., Popat Sanjay. Polymorphic sequence variants in medicine: a challenge and an opportunity. Clin Med (Lond) 2003 May-Jun;3(3):260–264. doi: 10.7861/clinmedicine.3-3-260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hurley Carolyn Katovich. HLA diversity: detection and impact on unrelated hematopoietic stem cell donor characterization and selection. Int J Hematol. 2002 Aug;76 (Suppl 2):152–154. doi: 10.1007/BF03165107. [DOI] [PubMed] [Google Scholar]
  20. Issa A. M. Ethical considerations in clinical pharmacogenomics research. Trends Pharmacol Sci. 2000 Jul;21(7):247–249. doi: 10.1016/s0165-6147(00)01493-0. [DOI] [PubMed] [Google Scholar]
  21. Kaiser Jocelyn. Biobanks. Population databases boom, from Iceland to the U.S. Science. 2002 Nov 8;298(5596):1158–1161. doi: 10.1126/science.298.5596.1158. [DOI] [PubMed] [Google Scholar]
  22. Kaiser Jocelyn. Biobanks. Private biobanks spark ethical concerns. Science. 2002 Nov 8;298(5596):1160–1160. doi: 10.1126/science.298.5596.1160. [DOI] [PubMed] [Google Scholar]
  23. Kaiser Jocelyn. Genomic medicine. African-American population biobank proposed. Science. 2003 Jun 6;300(5625):1485–1485. doi: 10.1126/science.300.5625.1485. [DOI] [PubMed] [Google Scholar]
  24. Kaye J., Martin P. Safeguards for research using large scale DNA collections. BMJ. 2000 Nov 4;321(7269):1146–1149. doi: 10.1136/bmj.321.7269.1146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lee S. S., Mountain J., Koenig B. A. The meanings of "race" in the new genomics: implications for health disparities research. Yale J Health Policy Law Ethics. 2001 Spring;1:33–75. [PubMed] [Google Scholar]
  26. Reymond M. A., Steinert R., Escourrou J., Fourtanier G. Ethical, legal and economic issues raised by the use of human tissue in postgenomic research. Dig Dis. 2002;20(3-4):257–265. doi: 10.1159/000067677. [DOI] [PubMed] [Google Scholar]
  27. Rial-Sebbag E. Aspects juridiques des banques d'échantillons biologiques. Rev Epidemiol Sante Publique. 2003 Feb;51(1 Pt 2):111–119. [PubMed] [Google Scholar]
  28. Stegmayr Birgitta, Asplund Kjell. Genetisk forskning på blodprov som förvarats länge i medicinsk biobank. De flesta människor är positiva till att ge informerat samtycke. Lakartidningen. 2003 Feb 20;100(8):618–620. [PubMed] [Google Scholar]

Articles from Comparative and Functional Genomics are provided here courtesy of Wiley

RESOURCES